Vanaporn WuthiekanunPremjit AmornchaiNatnaree SaipromNarisara ChantratitaWirongrong ChierakulGavin C K W KohWipada ChaowagulNicholas P J DayDirek LimmathurotsakulSharon J. PeacockMahidol UniversitySappasitthiprasong HospitalNuffield Department of Clinical MedicineUniversity of Cambridge2018-05-032018-05-032011-11-01Antimicrobial Agents and Chemotherapy. Vol.55, No.11 (2011), 5388-539110986596006648042-s2.0-80054710806https://repository.li.mahidol.ac.th/handle/20.500.14594/12252A 21-year survey conducted in northeast Thailand of antimicrobial resistance to parenteral antimicrobial drugs used to treat melioidosis identified 24/4,021 (0.6%) patients with one or more isolates resistant to ceftazidime (n ∇ 8), amoxicillin-clavulanic acid (n ∇ 4), or both drugs (n ∇ 12). Two cases were identified at admission, and the remainder were detected a median of 15 days after starting antimicrobial therapy. Resistance to carbapenem drugs was not detected. These findings support the current prescribing recommendations for melioidosis. Copyright © 2011 American Society for Microbiology. All Rights Reserved.Mahidol UniversityMedicinePharmacology, Toxicology and PharmaceuticsArticleSCOPUS10.1128/AAC.05517-11